Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Sanofi Influenza Vaccines Romania 2025/2026 - News Directory 3

Sanofi Influenza Vaccines Romania 2025/2026

September 17, 2025 Jennifer Chen Health
News Context
At a glance
  • Flu vaccines are readily available from⁤ community pharmacies and medical clinics, frequently enough covered by insurance.
  • The high-dose ‍influenza vaccine is specifically indicated for the seasonal immunization of people aged 60 and over, offering a ⁢demonstrably higher⁤ level of protection against ⁤influenza and ⁢the...
  • As individuals age, their immune systems naturally weaken, making them more vulnerable to infections like influenza.
Original source: economica.net

“`html





<a href="https://www.newsdirectory3.com/comptroller-generals-department-trials-high-dose-flu-vaccine-mcot-plc/" title="Comptroller General's Department Trials High-Dose Flu Vaccine - MCOT Plc">High-Dose Flu Vaccine</a> for Seniors: Enhanced Protection Against Influenza


High-Dose Flu Vaccine: Enhanced Protection for Seniors

Table of Contents

  • High-Dose Flu Vaccine: Enhanced Protection for Seniors
    • At a Glance
    • The Changing ⁢Landscape of flu Vaccines
    • Differentiated Protection Against Influenza and Complications
      • Influenza⁢ Impact: Data ⁢from the 2024/2025 Season

At a Glance

  • What: A high-dose influenza vaccine designed for individuals aged 60 and over.
  • Where: Available at community pharmacies and medical clinics with a prescription, often covered by insurance.
  • When: Recommended annually, ideally starting in October.
  • why ⁤it Matters: Seniors have⁤ weakened immune systems and are at higher risk of severe flu complications like pneumonia and hospitalization.
  • What’s Next: The WHO and EMA are transitioning to recommending only tetravalent vaccines starting in the 2025/2026 flu ⁣season.

The Changing ⁢Landscape of flu Vaccines

Flu vaccines are readily available from⁤ community pharmacies and medical clinics, frequently enough covered by insurance. A meaningful shift ⁢is occurring in vaccine recommendations. Both ⁢trivalent and ⁤tetravalent influenza vaccines currently meet World Health Association (WHO)⁣ and European Medicines Agency (EMA) standards. However, starting ⁣with the 2025/2026⁣ flu season, the WHO and EMA have established that only tetravalent influenza vaccines will be marketed in the European Union, ⁢reflecting the evolution ⁤of circulating viral strains.

Differentiated Protection Against Influenza and Complications

The high-dose ‍influenza vaccine is specifically indicated for the seasonal immunization of people aged 60 and over, offering a ⁢demonstrably higher⁤ level of protection against ⁤influenza and ⁢the severe complications associated with ⁣it.

As individuals age, their immune systems naturally weaken, making them more vulnerable to infections like influenza. This increased vulnerability translates to a higher risk of developing serious complications such as pneumonia, severe ⁤cardiac ‍issues, and exacerbation of chronic conditions (including cardiac, lung, and ‍metabolic diseases).Alarmingly, up to one in three elderly individuals hospitalized due to the⁤ flu will develop pneumonia, and full recovery can take between 6 and 12 weeks.

Furthermore, the presence of comorbidities significantly increases the ⁣risk ⁢of flu-related complications and hospitalizations in the elderly. A sobering ‍statistic reveals that only one in three people over 70 years old,⁤ hospitalized with an acute infection like the flu, fully recovers after one year.

Influenza⁢ Impact: Data ⁢from the 2024/2025 Season

Data from the National⁢ Institute of Public Health (INSP) for the 2024/2025 influenza⁤ season highlights the disproportionate impact of the flu on seniors.A staggering 76% of reported deaths occurred in individuals aged 65 and over, and nearly half of all⁢ influenza hospitalizations were within this age group. Of the 117,055‍ clinical cases compatible‍ with

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • Study: Cholesterol-Lowering Drugs May Cause Muscle Pain and Weakness
  • FTC Sues Hims & Hers Over Deceptive Business Practices and Data Privacy
  • Romania’s Paul to Be Extradited From France After Final Court Appeal Rejected (newsy-today.com)

Related

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com